Immunohistochemistry analysis revealed that MIA-690 and, to a greater extent, cisplatin/pemetrexed, reduced tumor cell proliferation, as assessed by decreased number of both mitotic and Ki-67 positive cells, while increasing apoptosis, as indicated by enhanced staining for cleaved caspase-3. This evidence concerns the gene CASP3 and neoplasm.